Great West Life Assurance CO Cyclerion Therapeutics, Inc. Transaction History

Great West Life Assurance CO

  • $57.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 17, 2020
SELL
$2.37 - $7.14 $2,488 - $7,497
-1,050 Closed
0 $0
Q4 2019

Feb 11, 2020
BUY
$1.8 - $13.43 $1,890 - $14,101
1,050 New
1,050 $2,000
Q3 2019

Oct 25, 2019
SELL
$8.12 - $14.54 $16,069 - $28,774
-1,979 Closed
0 $0
Q2 2019

Jul 31, 2019
BUY
$9.6 - $22.85 $18,998 - $45,220
1,979 New
1,979 $0

Others Institutions Holding CYCN

# of Institutions
1
Shares Held
293K
Call Options Held
0
Put Options Held
0
View Full List

About Cyclerion Therapeutics, Inc.

CYCN Quotes by TradingView
  • Ticker CYCN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,479,800
  • Market Cap $139M
  • Description
  • Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...
More about CYCN
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email